Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 4
2011 1
2012 1
2013 2
2014 4
2015 2
2016 2
2017 2
2018 2
2019 3
2020 1
2021 5
2022 1
2024 2
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Antipsychotics as antidepressants.
Roberts RJ, Lohano KK, El-Mallakh RS. Roberts RJ, et al. Asia Pac Psychiatry. 2016 Sep;8(3):179-88. doi: 10.1111/appy.12186. Epub 2015 May 12. Asia Pac Psychiatry. 2016. PMID: 25963405 Review.
Three second-generation antipsychotic (SGA) agents have received FDA approval for adjunctive treatment, to antidepressant, of major depressive disorder: quetiapine, aripiprazole, and olanzapine. Additionally, quetiapine and lurasidone have been approved for the treatment o …
Three second-generation antipsychotic (SGA) agents have received FDA approval for adjunctive treatment, to antidepressant, of major depressi …
Aripiprazole in Children and Adolescents.
Coustals N, Ménard ML, Cohen D. Coustals N, et al. J Child Adolesc Psychopharmacol. 2021 Feb;31(1):4-32. doi: 10.1089/cap.2020.0014. Epub 2020 Sep 15. J Child Adolesc Psychopharmacol. 2021. PMID: 32931315 Review.
Objective: To review the use of aripiprazole in children and adolescents. Methods: Medline and Embase databases were systematically searched using the keywords aripiprazole and child or adolescent over the period from 2000 to 2019. ...In addition, off-label prescrip …
Objective: To review the use of aripiprazole in children and adolescents. Methods: Medline and Embase databases were systematically s …
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.
Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, Bordet R, Rolland B. Carton L, et al. Curr Pharm Des. 2015;21(23):3280-97. doi: 10.2174/1381612821666150619092903. Curr Pharm Des. 2015. PMID: 26088115
Among children, OLP was estimated between 36 and 93.2% of all antipsychotic prescriptions. Risperidone and aripiprazole were primarily used and were most often prescribed for attention deficit hyperactivity disorder, anxiety, or mood disorders. ...
Among children, OLP was estimated between 36 and 93.2% of all antipsychotic prescriptions. Risperidone and aripiprazole were primaril …
Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain.
García-Carmona JA, Simal-Aguado J, Campos-Navarro MP, Valdivia-Muñoz F, Galindo-Tovar A. García-Carmona JA, et al. Int Clin Psychopharmacol. 2021 Jul 1;36(4):201-207. doi: 10.1097/YIC.0000000000000357. Int Clin Psychopharmacol. 2021. PMID: 33853106
Patients treated with LAIs showed a decreased ratio of visits to emergency compared with the oral treatment group, and between LAIs, PP3M vs. aripiprazole-1-month group. Furthermore, patients treated with LAIs used lower number and dose of concomitant antipsychotics compar …
Patients treated with LAIs showed a decreased ratio of visits to emergency compared with the oral treatment group, and between LAIs, PP3M vs …
Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists.
Aguglia A, Serafini G, Nebbia J, Salvi V, Martinotti G, Corbo M, Signorelli MS, Mineo L, Mencacci C, Di Sciascio G, Biggio G, Aguglia E, Amore M. Aguglia A, et al. J Pers Disord. 2021 Jun;35(3):321-335. doi: 10.1521/pedi_2019_33_445. Epub 2019 Oct 14. J Pers Disord. 2021. PMID: 31609189
The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SGAs represents a common clinical practice in accordance with a worldwide trend, the use of long-acting injection formulations was considered …
The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SG …
Low to moderate-dose off-label use of second-generation antipsychotics seems to be safe in the light of cardiac adverse effects in child psychiatric patients.
Kakko K, Salmelin R, Puura K, Poutanen T. Kakko K, et al. Eur J Pediatr. 2025 Sep 11;184(10):609. doi: 10.1007/s00431-025-06447-4. Eur J Pediatr. 2025. PMID: 40932558 Free PMC article.
The study patients (n = 55, 76% males, median age 9.9 years) were followed for a median of 9 months. In all of them SGA (risperidone, aripiprazole, quetiapine) treatment was off-label. The median olanzapine equivalent dose was 2.0 mg. ...
The study patients (n = 55, 76% males, median age 9.9 years) were followed for a median of 9 months. In all of them SGA (risperidone, ari …
Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A, de Haan L. Scheltema Beduin A, et al. Psychopharmacol Bull. 2010;43(3):45-81. Psychopharmacol Bull. 2010. PMID: 21150846 Review.
In this review we describe the evidence that supports off-label use of the second generation antipsychotics risperidone, olanzapine, clozapine, ziprasidone, quetiapine and aripiprazole in impulse regulation disorders and substance abuse disorders. We discuss these disorder …
In this review we describe the evidence that supports off-label use of the second generation antipsychotics risperidone, olanzapine, clozapi …
Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists.
Salvi V, Cerveri G, Aguglia A, Calò S, Corbo M, Martinotti G, Serafini G, Signorelli MS, Aguglia E, Amore M, Biggio G, DI Sciascio G, Mencacci C. Salvi V, et al. J Psychiatr Pract. 2019 Jul;25(4):318-327. doi: 10.1097/PRA.0000000000000405. J Psychiatr Pract. 2019. PMID: 31291215
With regard to the use of specific SGAs in BD, off-label aripiprazole was considered appropriate for depressive episodes by 46% of the psychiatrists, followed by olanzapine which was considered appropriate by 33.7%. For maintenance treatment of BD, off-label asenapine was …
With regard to the use of specific SGAs in BD, off-label aripiprazole was considered appropriate for depressive episodes by 46% of th …
Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Maher AR, et al. JAMA. 2011 Sep 28;306(12):1359-69. doi: 10.1001/jama.2011.1360. JAMA. 2011. PMID: 21954480
Controlled trials comparing an atypical antipsychotic medication (risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, asenapine, iloperidone, or paliperidone) with placebo, another atypical antipsychotic medication, or other pharmacotherapy for adult off-label …
Controlled trials comparing an atypical antipsychotic medication (risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, ase …
33 results